Skip to main content
SpringerLink
Log in

Advances in the Pharmacological Treatment of Pathological Gambling

  • Published:
Journal of Gambling Studies Aims and scope Submit manuscript

Abstract

In the present paper we discuss the current status of drug treatment for pathological gambling and the scientific rationales underlying the various pharmacological approaches. Specifically, we summarize the treatment study results of serotonin reuptake inhibitors, mood stabilizers, opioid antagonists, and atypical antipsychotics in pathological gambling. We also discuss dosage strategies, the duration of treatment, issues surrounding medication compliance, and approaches to treatment-refractory pathological gambling, such as pharmacological and behavioral augmentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albanese, M.J., Khantzian, E.J., Murphy, S.L., & Green, A.I. (1994). Decreased substance use in chronically psychotic patients treated with clozapine. American Journal of Psychiatry, 151, 780–781. [Letter].

    Google Scholar 

  • American Psychiatric Association Committee on Nomenclature and Statistics. (1980). Diagnostic and statistical manual of mental disorders (3rd Ed.). Washington, D.C.: American Psychiatric Association.

    Google Scholar 

  • American Psychiatric Association Committee on Nomenclature and Statistics. (1987). Diagnostic and statistical manual of mental disorders (3rd Ed.-Revised). Washington, D.C.: American Psychiatric Association.

    Google Scholar 

  • American Psychiatric Association Committee on Nomenclature and Statistics. (2000). Diagnostic and statistical manual of mental disorders (4th Ed.-Text Revision). Washington, D.C.: American Psychiatric Association.

    Google Scholar 

  • Barrett, R.P., Feinstein, C., & Hole, W.T. (1989). Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis. American Journal of Mental Retardation, 93, 644–651.

    Google Scholar 

  • Blanco, C., Moreyra, P., Nunes, E.V., Sáiz-Ruiz, J., & Ibánez, A. (2001). Pathological gambling: addiction or compulsion? Seminars in Clinical Neuropsychiatry, 6, 167–176.

    Google Scholar 

  • Blanco, C., Orensanz-Munoz, L., Blanco-Jerez, C., & Saiz-Ruiz, J. (1996). Pathological gambling and platelet MAO activity: a psychobiological study. American Journal of Psychiatry, 153, 119–121.

    Google Scholar 

  • Blanco, C., Petkova, E., Ibanez, A., & Sáiz-Ruiz, J. (2002). A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals of Clinical Psychiatry, 14, 9–15.

    Google Scholar 

  • Broekkamp, C.L. & Phillips, A.G. (1979). Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacology Biochemistry and Behavior, 11, 289–295.

    Google Scholar 

  • Buckley, P., Thompson, P., Way, L., & Meltzer, H.Y. (1994). Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. American Journal of Psychiatry, 151, 385–389.

    Google Scholar 

  • Carrasco, J.L., Saiz-Ruiz, J., Hollander, E., Cesar, J., & Lopez-Ibor Jr., J.J. (1994). Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatrica Scandinavia, 90, 427–3

    Google Scholar 

  • Carroll, K.M., Ball, S.A., Nich, C., O'Connor, P.G., Eagan, D.A., Frankforter, T.L., Triffleman, E.G., Shi, J., & Rounsaville, B.J. (2001). Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence. Archives of General Psychiatry, 58, 755–761.

    Google Scholar 

  • Chambers, R.A., Krystal, J. H., & Self, D.W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71–83.

    Google Scholar 

  • Chambers, R.A. & Potenza, M.N. (2001). Schizophrenia and pathological gambling. American Journal of Psychiatry, 158, 497–498. [Letter].

    Google Scholar 

  • Chambers, R.A. & Potenza, M.N. (in press). Impulse control disorders. In M.J. Adinoff & R.B. Daroff (Eds.), The encyclopedia of neurological sciences. San Diego, California: Academic Press.

  • Crockford, D.N. & el-Guebaly, N. (1998). Naltrexone in the treatment of pathological gambling and alcohol dependence. Canadian Journal of Psychiatry, 43, 86. [Letter].

    Google Scholar 

  • Cunningham-Williams, R.M. & Cottler, L.B. (2001). The epidemiology of pathological gambling. Seminars in Clinical Neuropsychiatry, 6:155–166.

    Google Scholar 

  • Cunningham-Williams, R.M., Cottler, L.B., Compton, W.M. 3rd, & Spitznagel, E.L. (1998). Taking chances: problem gamblers and mental health disorders—results from the St. Louis Epidemiologic Catchment Area Study. American Journal of Public Health. 88:1093–1096.

    Google Scholar 

  • Daly, K.A. & Fatemi, S.H. (1999). Lamotrogine and impulse behavior. Canadian Journal of Psychiatry, 44, 395-396. [Letter].

    Google Scholar 

  • Davidson, D., Swift, R.M., & Fitz, E. (1996). Naltrexone increases the latency to drink in social drinkers. Alcoholism and Clinical Experimental Research, 20, 732–739.

    Google Scholar 

  • DeCaria, C.M., Begaz, T., & Hollander, E. (1998). Serotonergic and noradrenergic function in pathological gambling. CNS Spectrums, 3, 38–47.

    Google Scholar 

  • DeCaria, C.M., Hollander, E., Grossman, R., Wong, C.M., Mosovich, S.A., & Cherkasky, S. (1996). Diagnosis, neurobiology, and treatment of pathological gambling. Journal of Clinical Psychiatry, 57(S8), 80–83.

    Google Scholar 

  • De la Gandara, J.J. (1999). Fluoxetine: open-trial in pathological gambling. Presented at the 152nd Annual Meeting of the American Psychiatric Association; May 16–21; Washington, DC. [Abstract].

  • Farren, C.K., Rezvani, A.H., Overstreet, D., & O'Malley, S. (2000). Combination pharmacotherapy in alcoholism: a novel treatment approach. CNS Spectrums, 5, 70–76.

    Google Scholar 

  • Feeney, D.J. & Klykylo, W.M. (1997). Treatment for kleptomania. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 723–724.

    Google Scholar 

  • Gardell, L.R., Reid, L.D., Boedeker, K.L., Liakos, T.M., & Hubbell, C.L. (1997a). Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Alcoholism and Clinical Experimental Research, 21, 1592–1598.

    Google Scholar 

  • Gardell, L.R., Whalen, C.A., Chattophadyay, S., Cavallaro, C.A., Hubbell, C.L., & Reid, L.D. (1997b). Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcoholism and Clinical Experimental Research, 21, 1435–1439.

    Google Scholar 

  • George, T.P. & Krystal, J.H. (2000). Comorbidity of psychiatric and substance abuse disorders. Current Opinion in Psychiatry, 13, 327–331.

    Google Scholar 

  • George, T.P., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J., Rounsaville, B. J., & Kosten, T.R. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.

    Google Scholar 

  • Gerstein, D., Hoffmann, J., Larison, C., Engelman, L., Murphy, S., Palmer, A., Chuchro, L., Toce, M., Johnson, R., Buie, T., & Hill, M.A. (1999). Gambling impact and behavior study. National Opinion Research Center, University of Chicago. http://www.norc.uchicago.edu/new/gambfin.htm".

  • Goodman, W.K., McDougle, C.J., Price, L.H., Riddle, M.A., Pauls, D.L., & Leckman, J.F. (1990). Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder? Journal of Clinical Psychiatry, 51, 36–43.

    Google Scholar 

  • Goodwin, F.K. & Jamison, K.R. (1990). Manic-depressive illness. New York City, NY: Oxford University Press.

    Google Scholar 

  • Grant, J.E. & Kim, S.W. (2001a). Demographic and clinical features of 131 adult pathological gamblers. Journal of Clinical Psychiatry, 62, 957–962.

    Google Scholar 

  • Grant, J.E. & Kim, S.W. (2001b). Pharmacotherapy of pathological gambling disorder. Psychiatric Annals, 32, 161–170.

    Google Scholar 

  • Grant, J.E. & Kim, S.W. (2002). An open label study of naltrexone in the treatment of kleptomania. Journal of Clinical Psychiatry, 63, 349–356.

    Google Scholar 

  • Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76–338. Rockville, MD: National Institute of Mental Health, 218–222.

    Google Scholar 

  • Haller, R. & Hinterhuber, H. (1994). Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry, 27, 129.

    Google Scholar 

  • Head, C.A., Vessichio, J.C., Sahady, D.M., Kosten, T.R., & George, T. P. (2000). Buproprion versus placebo for smoking cessation in schizophrenia: effects of atypical antipsychotic drugs. Presented at the 7 th Annual Meeting of the Society for Research of Nicotine and Tobacco. [Abstract].

  • Hollander, E. (2001). “Very bad behaviors” in the Symposium “The impulsive aggressive spectrum: Challenging populations.” Presented at the 154th Annual Meeting of the American Psychiatric Association; May 7 and 8; New Orleans, LA. [Abstract].

  • Hollander, E., DeCaria, C.M., Finkell, J.N., Begaz, T., Wong, C.M., & Cartwright, C. (2000). A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biological Psychiatry, 47, 813–817.

    Google Scholar 

  • Hollander, E., DeCaria, C.M., Mari, E., Wong, C.M., Mosovich, S., Grossman, R., & Begaz, T. (1998). Short-term single-blind fluvoxamine treatment of pathological gambling. American Journal of Psychiatry, 155, 1781–1783.

    Google Scholar 

  • Hollander, E., Frenkel, M., DeCaria, C., Trungold, S., & Stein, D.J. (1992). Treatment of pathological gambling with clomipramine. American Journal of Psychiatry, 149, 710–711. [Letter].

    Google Scholar 

  • Hollander, E. & Wong, C.M. (1995). Obsessive-compulsive spectrum disorders. Journal of Clinical Psychiatry, 56(S4), 3–6.

    Google Scholar 

  • Hollister, L., Schwin, R.L., & Kasper, P. (1977). Naltrexone treatment of opiate-dependent persons. Drug and Alcohol Dependence, 2, 203–209.

    Google Scholar 

  • Holmes, E.K., Mateczun, J.M., Lall, R., Wilcove, G.L. (1998). Pilot study of suicide risk factors among personnel in the United States Marine Corps (Pacific Forces). Psychological Reports, 83, 3–11.

    Google Scholar 

  • Jaffe, A.J., Rounsaville, B., Chang, G., Shottenfeld, R.S., Meyer, R.E., & O'Malley, S.S. (1996). Naltrexone, relapse prevention and supportive therapy with alcoholics: an analysis of patient matching. Journal of Consulting Clinical Psychology, 64, 1044–1053.

    Google Scholar 

  • Kane, J., Honigfeld, G., Singer, J, & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.

    Google Scholar 

  • Kapur, S. (1998). A new framework for investigating antipsychotic action in humans: lessons from PET imaging. Molecular Psychiatry, 3, 135–140.

    Google Scholar 

  • Kim, S.W. (1998). Opioid antagonists in the treatment of impulse control disorders. Journal of Clinical Psychiatry, 59, 159–164.

    Google Scholar 

  • Kim, S.W. & Grant, J.E. (2001a). An open naltrexone treatment study of pathological gambling disorder. International Clinical Psychopharmacology, 16, 285–289.

    Google Scholar 

  • Kim, S.W. & Grant, J.E. (2001b). The psychopharmacology of pathological gambling. Seminars in Clinical Neuropsychiatry, 6, 184–194.

    Google Scholar 

  • Kim, S.W. & Grant, J.E. (2001c). Personality dimensions in pathological gambling disorder and obsessive compulsive disorder. Psychiatry Research, 104, 205–212.

    Google Scholar 

  • Kim, S.W., Grant, J.E., Adson, D.E., & Remmel, R.P. (2001a). A preliminary report on a possible naltrexone and nonsteroidal analgesics interaction. Journal of Clinical Psychopharmacology, 21, 632–634. [Letter].

    Google Scholar 

  • Kim, S.W., Grant, J.E., Adson, D.E., & Shin, Y.C. (2001b). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry, 49, 914–921.

    Google Scholar 

  • Kim, S.W., Grant, J.E., Adson, D.E., Shin, Y.C., & Zaninelli, R.M. (2002). A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. Journal of Clinical Psychiatry, 63, 501–507.

    Google Scholar 

  • Ladouceur, R., Boisvert, J.M., & Dumont, J. (1994). Cognitive-behavioral treatment for adolescent pathological gamblers. Behavior Modification, 18, 230–242.

    Google Scholar 

  • Lesieur, H.R. & Rosenthal, R.J. (1991). Pathological gambling: a review of the literature (prepared for the American Psychiatric Association Task Force of DSM-IV Committee on Disorders of Impulse Control Not Elsewhere Classified). Journal of Gambling Studies, 7, 5–39.

    Google Scholar 

  • Mason, B.J. & Ownby, R.L. (2000). Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials. CNS Spectrums, 5, 58–69.

    Google Scholar 

  • Martin, A., Scahill, L., Vitulano, L., & King, R.A. (1998). Stimulant use and trichotillomania. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 349–50.

    Google Scholar 

  • Matthews, R.T. & German, D.C. (1984). Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience, 11, 617–625.

    Google Scholar 

  • McDougle, C.J., Epperson, C.N., Pelton, G.H., Wasylink, S., & Price, L.H. (2000). A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry, 57, 794–801.

    Google Scholar 

  • McDougle, C.J., Goodman, W.K., Leckman, J.F., Lee, N.C., Heninger, G.R., & Price, L.H. (1994). Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry, 51, 302–308.

    Google Scholar 

  • McElroy, S.L., Hudson, J.I., Phillips, K.A., Keck, P.E., & Pope, H.G. (1993). Clinical and theoretical implications of a possible link between obsessive-compulsive and impulse control disorders. Depression, 1, 121–132.

    Google Scholar 

  • McElroy, S.L., Pope, H.G. Jr., Keck, P.E., Hudson, J.I., Phillips, K.A., & Strakowski, S.M. (1996). Are impulse-control disorders related to bipolar disorder? Comprehensive Psychiatry, 37, 229–240.

    Google Scholar 

  • McLellan, A.T., Arndt, I.O., Metzger, D.S., Woody, G.E., & O'Brien, C.P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 1953–1959.

    Google Scholar 

  • Meltzer, H. Y. (1995). Atypical antipsychotic drugs. In F.E. Bloom & D.J. Kupfer (Eds), Neuropsychopharmacology: the fourth generation of progress. New York: D.J. Raven Press.

    Google Scholar 

  • Meltzer, H. Y. (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 21, 106S–115S.

    Google Scholar 

  • Mitchell, J.E., Morley, J.E., Levine, A.S., Hatsukami, D., Gannon, M., & Pfohl, D. (1987). High-dose naltrexone therapy and dietary counseling for obesity. Biological Psychiatry, 22, 35–42.

    Google Scholar 

  • Monti, P.M, Rohsenow, D.J., Hutchison, K., Swift, R.M., Mueller, T.I., Colby, S.M., Brown, R.A., Gulliver, S.B., Gordon, A., & Abrams, D.B. (1999). Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcoholism and Clinical Experimental Research, 23, 1386–1394.

    Google Scholar 

  • Monti, P.M, Rohsenow, D.J., Swift, R.M., Abrams, D.B., Colby, S.M., & Mueller, T.I. (1996). Effect of naltrexone on urge to drink during alcohol cue exposure: preliminary results. Alcoholism and Clinical Experimental Research, 20, 92A.

    Google Scholar 

  • Moskowitz, J.A. (1980). Lithium and lady luck: use of lithium carbonate in compulsive gambling. New York State Journal of Medicine, 80, 785–788.

    Google Scholar 

  • Nordin, C. & Eklundh, T. (1999). Altered CSF 5-HIAA disposition in pathologic male gamblers. CNS Spectrums, 4, 25–33.

    Google Scholar 

  • O'Brien, C.P. (1997). A range of research-based pharmacotherapies for addiction. Science, 278, 66–70.

    Google Scholar 

  • O'Malley, S.S., Jaffe, A.J., Chang, G., Schottenfeld, R.S., Meyer, R.E., & Rounsaville, B.J. (1992). Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry, 49, 881–887.

    Google Scholar 

  • Pallanti, S., Quercioli, L., Sood, E., & Hollander E. (2002). Lithium and valproate treatment of pathological gambling: a randomized single-blind study. Journal of Clinical Psychiatry, 63, 559–564.

    Google Scholar 

  • Petry, N.M. & Armentano, C. (1999). Prevalence, assessment, and treatment of pathological gambling: a review. Psychiatric Services, 50, 1021–1027.

    Google Scholar 

  • Petry, N.M. & Roll, J.M. (2001). A behavioral approach to understanding and treating pathological gambling. Seminars in Clinical Neuropsychiatry, 6, 177–183.

    Google Scholar 

  • Phillips, A.G. & LePiane, F.G. (1980). Reinforcing effects of morphine microinjection onto the ventral tegmental area. Pharmacology Biochemistry and Behavior, 12, 965–968.

    Google Scholar 

  • Phillips, D.P., Welty, W.R., & Smith, M.M. (1997). Elevated suicide levels associated with legalized gambling. Suicide and Life Threatening Behavior, 27, 373–378.

    Google Scholar 

  • Physicians' Desk Reference (2001). 55th Ed. Medical Economics Company. Montvale, NJ.

  • Potenza, M.N. (2001). The neurobiology of pathological gambling. Seminars in Clinical Neuropsychiatry, 6, 217–226.

    Google Scholar 

  • Potenza, M.N. (2002). A perspective on future directions in the prevention, treatment and research of pathological gambling. Psychiatric Annals, 32, 203–207.

    Google Scholar 

  • Potenza, M.N., Fiellin, D.A., Heninger, G.R., Rounsaville, B.J., & Mazure, C.M. (2002). Gambling: an addictive behavior with primary care implications. Journal of General Internal Medicine, 17, 1–12.

    Google Scholar 

  • Potenza, M.N. & Hollander, E. (2002). Pathological gambling and impulse control disorders. In J. Coyle, C. Nemeroff, D. Charney, & K. Davis (Eds), Neuropsychopharmacology: the 5th generation of progress (pp. 1725–1741). Baltimore, MD: Lippincott Williams and Wilkens.

    Google Scholar 

  • Potenza, M.N., Kosten, T.R., & Rounsaville, B.J. (2001). Pathological gambling. Journal of the American Medical Association, 286, 141–144.

    Google Scholar 

  • Potenza, M.N. & McDougle, C.J. (1998). Potential of atypical antipsychotics in the treatment of non-psychotic disorders. CNS Drugs, 9, 213–232.

    Google Scholar 

  • Potenza, M.N., Steinberg, M.A., McLaughlin, S.D., Wu, R., Rounsaville, B.J., & O'Malley, S.S. (2000). Illegal behaviors in problem gambling: analysis of data from a gambling helpline. Journal of the American Academy of Psychiatry and the Law, 28, 389–403.

    Google Scholar 

  • Roth, A.S., Ostroff, R.B., & Hoffman, R.E. (1996). Naltrexone as a treatment for repetitive self-injurious behaviour: an open-label trial. Journal of Clinical Psychiatry, 57, 233–237.

    Google Scholar 

  • Rounsaville, B.J. (1995). Can psychotherapy rescue naltrexone treatment of opioid addiction? In L.S. Onken & J.D. Blaine (Eds.), Potentiating the effects of medications. Rockville, Maryland: National Institute on Drug Abuse Research Monograph, 105, 37–52.

    Google Scholar 

  • Rugle, L. (2000). The use of olanzapine in the treatment of video poker pathological gamblers. Presented at the conference entitled, “The Comorbidity of Pathological Gambling: A Current Research Synthesis” December 3–5; Las Vegas, Nevada. [Abstract].

  • Saxena, S., Wang, D., Bystritsky, A., & Baxter, L.R. (1996). Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. Journal of Clinical Psychiatry, 57, 303–306.

    Google Scholar 

  • Seeman, P. (1992). Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology, 7, 261–284.

    Google Scholar 

  • Shaffer, H.J. & Hall, M.N. (1996). Estimating the prevalence of adolescent gambling disorders: a quantitative synthesis and guide toward standard gambling nomenclature. Journal of Gambling Studies, 12, 193–214.

    Google Scholar 

  • Shaffer, H.J., Hall, M.N., & Vander Bilt, J. (1999). Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. American Journal of Public Health, 89, 1369–1376.

    Google Scholar 

  • Shinohara, K., Yanagisawa, A., Kagota, Y., Gomi, A., Nemoto, K., Moriya, E., Furusawa, E., Furuya, K., & Tersawa, K. (1999). Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate. Applied Human Science, 18, 37–42.

    Google Scholar 

  • Stein, D.J., Bouwer, M.B., Hawkridge, S., & Emsley, R.A. (1997). Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. Journal of Clinical Psychiatry, 58, 119–122.

    Google Scholar 

  • Stewart, J. (1984). Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacology Biochemistry and Behavior, 20, 917–923.

    Google Scholar 

  • Sutherland, G., Stapleton, J.A., Russell, M.A.H., & Feyerabend, C. (1995). Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology, 120, 418–425.

    Google Scholar 

  • Swift, R.M. (2000). Opioid antagonists and alcoholism treatment. CNS Spectrums, 5, 49–57.

    Google Scholar 

  • Sylvain, C., Ladouceur, R., & Boisvert, J.M. (1997). Cognitive and behavioral treatment of pathological gambling: a controlled study. Journal of Consulting and Clinical Psychology, 65, 727–732.

    Google Scholar 

  • van Wolfswinkel, L. & van Ree, J.M. (1985). Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation. Naunyn-Schmiedebergs Archives of Pharmacology, 330, 84–92.

    Google Scholar 

  • Verebey, K.G. & Mule, S.J. (1985). Naltrexone (Trexan): a review of hepatotoxicity issues. NIDA Research Monograph, 67, 73–81.

    Google Scholar 

  • Volkow, N.D., & Fowler, J.S. (2000). Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex, 10, 318–325.

    Google Scholar 

  • Volpicelli, J.R., Alterman, A.I., Hayashida, M., & O'Brien, C.P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876–880.

    Google Scholar 

  • Volpicelli, J.R., Rhines, K.C., Rhines, J.S., Volpicelli, L.A., Alterman, A.I., & O'Brien, C.P. (1997). Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry, 54, 737–742.

    Google Scholar 

  • Walters, A.S., Barrett, R.P., Feinstein, C., Mercurio, A., & Hole, W.T. (1990). A case report of naltrexone treatment of self-injury and social withdrawal in autism. Journal of Autism and Developmental Disorders, 20, 169–176.

    Google Scholar 

  • Zimmerman, M. & Breen, R. (2002). An open-label study of citalopram in the treatment of pathological gambling. Journal of Clinical Psychiatry, 63, 44–48.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Minnesota School of Medicine, 2450 Riverside Avenue, Minneapolis, MN, 55454-1495

    Jon E. Grant

  2. University of Minnesota, USA

    Suck Won Kim

  3. Yale University, USA

    Marc N. Potenza

Authors
  1. Jon E. Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suck Won Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc N. Potenza
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grant, J.E., Won Kim, S. & Potenza, M.N. Advances in the Pharmacological Treatment of Pathological Gambling. J Gambl Stud 19, 85–109 (2003). https://doi.org/10.1023/A:1021227214142

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021227214142

Search

Navigation